RemeGen Co., Ltd.
REGMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,710 | $1,076 | $768 | $1,424 |
| % Growth | 58.9% | 40.2% | -46.1% | – |
| Cost of Goods Sold | $343 | $253 | $270 | $67 |
| Gross Profit | $1,367 | $823 | $498 | $1,357 |
| % Margin | 80% | 76.5% | 64.8% | 95.3% |
| R&D Expenses | $1,540 | $1,306 | $982 | $711 |
| G&A Expenses | $332 | $314 | $273 | $220 |
| SG&A Expenses | $1,281 | $1,089 | $713 | $483 |
| Sales & Mktg Exp. | $949 | $775 | $441 | $263 |
| Other Operating Expenses | -$83 | -$70 | -$143 | $0 |
| Operating Expenses | $2,738 | $2,325 | $1,552 | $1,194 |
| Operating Income | -$1,371 | -$1,502 | -$1,054 | $163 |
| % Margin | -80.2% | -139.6% | -137.3% | 11.4% |
| Other Income/Exp. Net | -$98 | -$9 | $55 | $113 |
| Pre-Tax Income | -$1,468 | -$1,511 | -$999 | $276 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,468 | -$1,511 | -$999 | $276 |
| % Margin | -85.9% | -140.4% | -130.1% | 19.4% |
| EPS | -2.73 | -2.8 | -1.88 | 0.57 |
| % Growth | 2.5% | -48.9% | -429.8% | – |
| EPS Diluted | -2.73 | -2.8 | -1.88 | 0.57 |
| Weighted Avg Shares Out | 537 | 540 | 530 | 487 |
| Weighted Avg Shares Out Dil | 538 | 540 | 531 | 487 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $28 | $62 | $43 |
| Interest Expense | $72 | $23 | $7 | $5 |
| Depreciation & Amortization | $301 | $240 | $186 | $120 |
| EBITDA | -$1,095 | -$1,248 | -$806 | $402 |
| % Margin | -64.1% | -116% | -104.9% | 28.2% |